Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology

Yaoxue Xuebao

Volumn 55, Issue 3, 2020, Pages 374-383

  Wu, Hao ^a   Wang, Jia Qi ^a   Yang, Yu Wei ^a   Li, Tian Yi ^a   Cao, Yi Jia ^a   Qu, Yu Xia ^a   Jin, Yu Jie ^b   Zhang, Chen Ning ^a,b   Sun, Yi Kun ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

COVID 19; Molecular docking technology; Network pharmacology; Preliminary exploration; Qingfei Paidu decoction

Indexed keywords

ANTI-SARS-COV-2 AGENT; CHINESE MEDICINAL FORMULA; QINGFEI PAIDU DECOCTION; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINESE MEDICINE; CORONAVIRUS DISEASE 2019; DRUG MECHANISM; HUMAN; MALE; MOLECULAR DOCKING; NONHUMAN; PHARMACOLOGICAL PARAMETERS;

EID: 85095415063     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: 10.16438/J.0513-4870.2020-0136     Document Type: Article

References (18)

1. Nguyen TM, Zhang Y, Pandolfi PP. Vuus against virus: a potential treatment for 2019-nCoV (SARS-CoV-2) and other RNA viruses [J]. Cell Res, 2020. DOI: 10.1038/s41422-020-0290-0.
2. Liu QY, Wang XL. Strategies for the development of drugs targeting novel coronavirus 2019-nCoV [J]. Acta Pharm Sin, 2020. DOI: 10.16438/J.0513-4870.2020-0106.
3. Song G, Cheng MQ, Wei XW. Research progress on novel coronavirus (2019-nCoV) related drugs in vitro/vivo [J]. Chin J Virol, 2020. DOI: 10.13242/j.cnki.bingduxuebao. 003646.
4. Liu CX, Wang YL, Yan FY. Understanding novel coronavirus pneumonia, paying attention to research and development of epidemic prevention and control drugs [J]. Chin J Antibio, 2020. DOI: 10.13461/j.cnki.cja.006858.
5. Guo ZR. Redisiver from sympathetic medication to phase in clinical study [J]. Acta Pharm Sin, 2020. DOI: 10.16438/J.0513-4870.2020-0103.
6. Xu X, Zhang Y, Li X, et al. Analysis on prevention plan of corona virus disease-19 (COVID-19) by traditional Chinese medicine in various regions [J]. Chin Tradit Herbal Drugs, 2020. http://kns. cnki. net/kcms/detail/12.1108.R. 20200214.1506.002. html.
7. Zheng WK, Zhang JH, Yang FW, et al. A compenhensive analysis on the diagnosis and treatment of coronavirus disease-19 (COVID-19) by traditional Chinese medicine [J]. J Tradit Chin Med, 2020. http://kns.cnki.net/kcms/detail/11.2166.r.20200206. 1113.002.html.
8. Wang YG, Qi WS, Ma JJ, et al. A preliminary study on the clinical characteristics and dialectical treatment of coronavirus disease-19 (COVID-19) by traditional Chinese medicine [J]. J Tradit Chin Med, 2020. http://kns.cnki.net/kcms/detail/ 11.2166.R.20200129.1258.002 .html.
9. Niu M, Wang RL, Wang ZX, et al. Rapid establishment of traditional Chinese medicine prevention and treatment for the novel coronavirus pneumonia based on clinical experience and molecular docking [J]. Chin J Chin Mater Med, 2020. DOI:10.19540/j.cnki.cjcmm.20200206.501.
10. Zong Y, Ding ML, Jia KK, et al. Exploring the active compounds of Da-Yuan-Yin in treatment of novel coronavirus (2019-nCoV) pneumonia based on network pharmacology and molecular docking method [J]. Chin Tradit Herbal Drugs, 2020. http://kns. cnki.net/kcms/detail/12.1108.r.20200209.1038.002Jitml. (11] Xue BS, Yao KW, Xue YX. Traditional Chinese medicine theory analysis on the rapid and effective treatment of novel coronavirus (2019-nCoV) pneumonia by "Qingfei Paidu decoction" [J]. J Tradit Chin Med, 2020. http://kns.cnki.net/kcms/ detail/11.2166.R.20200216.2004.002.html.
11. Hopkins AL. Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Biol, 2008, 4: 682-690.
12. Ren J, Wei J. Application of molecular docking technology in the study of traditional Chinese medicine [J]. Chin J Inf Tradit Chin Med, 2014; 21: 123-125.
13. Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein forrisk of human transmission [J]. Sci China Life Sci, 2020. DOI: 10.1007/sl 1427-020-1637-5.
14. Li F, Li W, Farzan M, et al. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor [J]. Science, 2005, 309:1864-1868.
15. Qian JQ, Zhu HM, Fang ZZ, et al. Simultaneous determination of ten constituents in Yifei Qinghua Granules by HPLC-DAD [J]. Chin Tradit Herb Drugs, 2018, 49: 94-99.
16. Hou AR, Xing YZ, Wu XS. Simultaneous determination of seven active ingredients in Erchen pills by HPLC-CAD [J]. Chin J Pharm Anal, 2019, 39: 662-668.
17. Meng YH, Meng XY, Zhang ZP, et al. Determination of atractylone and other four effective components in Atractylodes macrocephala and its processed products by HPLC [J]. Chemical Engineer, 2019, 33:24-26.
18. Tang L, Li Q, Bai J, et al. Severe pneumonia mortality in elderly patients is associated with downregulation of Toll-like receptors 2 and 4 on monocytes [J]. Am J Med Sci, 2014, 347:34-41.